Table 3.
Group | GSH (μmol/mg protein) | SOD (U/mg protein) | TBARS (nmol/mg protein) | ||||||
---|---|---|---|---|---|---|---|---|---|
Serum | Liver | Kidney | Serum | Liver | Kidney | Serum | Liver | Kidney | |
Control (n = 10) |
13.7 ± 3.1 | 69.9 ± 7.3 | 57.7 ± 9.2 | 3.8 ± 0.6 | 289.5 ± 37.3 | 267.7 ± 23.4 | 27.4 ± 4.2 | 48.6 ± 6.2 | 37.4 ± 5.9 |
Cd (n = 15) |
4.7 ± 0.9* | 11.7 ± 1.2* | 13.74 ± 1.7* | 1.2 ± 0.2* | 64.8 ± 8.2* | 71.5 ± 6.7* | 116.2 ± 23.4* | 1019.5 ± 195.9* | 1113.3 ± 195.9* |
Cd + CAPE (n = 15) |
12.2 ± 1.2# | 75.9 ± 11.4# | 68.7 ± 10.2# | 3.3 ± 0.8# | 305.3 ± 50.5# | 311.5 ± 47.8# | 36.74 ± 5.8# | 87.2 ± 14.6# | 118.6 ± 23.29# |
The values are presented as means ± SD. (Cd) cadmium, (CAPE) caffeic acid phenyl ester, (GSH) total glutathione, (SOD) superoxide dismutase, and (TBARS) thiobarbituric acid reactive substances. *P < 0.05 versus control group; # P < 0.05 versus Cd group.